Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis

American Journal of Rhinology and Allergy

Volumn 25, Issue 6, 2011, Pages 383-387

  Bautista, Angela P ^a   Eisenlohr, Claudia P ^a   Lanz, Miguel J ^a  

^a Department of Allergy Asthma and Rhinosinusitis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOCETIRIZINE; NITRIC OXIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; MALE; NOSE SMEAR; PERENNIAL RHINITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN TEST; SYMPTOMATOLOGY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CETIRIZINE; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NITRIC OXIDE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84455189513     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3668     Document Type: Article

References (31)

1. Greiner AN. Allergic rhinitis: Impact of the disease and considerations for management. Med Clin North Am 90:17-38, 2006. (Pubitemid 41682029)
2. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc 31:370-374, 2010.
3. Durham SR. The inflammatory nature of Allergic Disease. Clin Exp Allergy 28(suppl 6):20-24, 1998.
4. Marple BF. Allergic rhinitis and inflammatory airway disease: Interactions within the unified airspace. Am J Rhinol Allergy 24:249-254, 2010.
5. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 27:358-362, 1997. (Pubitemid 27183357)
6. Struben VM, Wieringa MH, Feenstra L, et al. Nasal nitric oxide and nasal allergy. Allergy 61:665-670, 2006. (Pubitemid 43801399)
7. Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: Longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 62:378-384, 2007. (Pubitemid 46398806)
8. Kharitonov, SA Rajakulasingam, K, O'Connor, B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 99:58-64, 1997.
9. Kharitonov SA, and Barnes PJ. Clinical aspects of nitric oxide. Eur Respir J 16:781-792, 2000.
10. De Winter-de Groot K, and van der Ent C. Measurement of nasal nitric oxide: Evaluation of six different sampling methods. Eur J Clin Invest 39:72-77, 2009.
11. Kharitonov SA, Walker L, and Barnes PJ. Repeatability of standardized nasal nitric oxide measurements in healthy and asthmatic adults and children. Respir Med 99:1105-1114, 2005. (Pubitemid 41102647)
12. Struben V, Wieringa M, Mantingh C, et al. Nasal NO measurements by direct sampling from the nose during breath hold: Aspiration flow, nasal resistance and reproducibility. Eur Arch Otorhinolaryngol 263:723-728, 2006. (Pubitemid 44060975)
13. Wang DY, Hanotte F, De Vos C, et al. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy 56:339-343, 2001. (Pubitemid 32222616)
14. Gillard M, Van Der Perren C, Moguilevsky N, et al. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: Contribution of Lys (191) and Thr (194). Mol Pharmacol 61:391-399, 2002. (Pubitemid 34112814)
15. Walsh GM. Anti-inflammatory properties of antihistamines: An update. Clin Exp Allergy Rev 5:21-25, 2005. (Pubitemid 41039533)
16. Potter PC, and Pediatric Levocetirizine Study Group. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 58:893-899, 2003. (Pubitemid 37046688)
17. Patou J, De Smedt H, van Cauwenberge P, et al. Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy 36:972-981, 2006. (Pubitemid 44166616)
18. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces cost in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 114:838-844, 2004. (Pubitemid 39330255)
19. Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: Effects on symptoms, quality of life, and inflammatory parameters. Clin Exp Allergy 36:1161-1167, 2006. (Pubitemid 44342931)
20. Albanesi C, Pastore S, Fanales-Belasio E, et al. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 28:101-109, 1998. (Pubitemid 28053933)
21. Jazrawi E, Stirling R, and Chung KF. Effects of levocetirizide on eotaxin-induced eosinophil chemotaxis with or without interleukin-5 priming in vitro. Allergy 56(suppl 68):138, 2001.
22. Thomson L, Blylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 32:1187-1192, 2002. (Pubitemid 35007422)
23. Ciprandi G, Cirillo IG, Vizzacaro A, et al. Levocetirizine improves nasal symptoms and air flow in patients with persistent allergic rhinitis: a pilot study. Eur Ann Allergy Clin Immunol 37:25-29, 2005. (Pubitemid 40223286)
24. Ciprandi G, Cirillo IG, Vizzaccaro A, et al. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: A pilot study. Clin Exp Allergy 34:958-964, 2004. (Pubitemid 38824076)
25. Hasala H, Janka-Junttila N, Moilanen E, et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 28:582-589, 2007.
26. Bommarito L, Guida G, Heffler E, et al. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol 101:358-362, 2008.
27. American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide 2005. Am J Respir Crit Care Med 171:912-930, 2005.
28. Lanz MJ, Prendes S, Peyrou N, et al. Nasal nitric oxide as a noninvasive marker in the antibiotic treatment of acute bacterial sinusitis. J Allergy Clin Immunol 121:530-531, 2008. (Pubitemid 351215173)
29. Juniper EF, Guyatt GH, and Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivits: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93:413-423, 1994. (Pubitemid 24081781)
30. Barnes ML, Ward JH, Fardon TC, and Lipworth BJ. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy 36:676-684, 2006.
31. Ho CY, and Tan CT. Comparison of antileukotrienes and antihistamines in the treatment of allergic rhinitis. Am J Rhinol 21:439-443, 2007.